Samrat Pharmachem Limited has complied with its disclosure requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by publishing an extract of its standalone audited financial results for the quarter and year ended March 31, 2026. The company submitted the relevant intimation to the Department of Corporate Services, BSE Limited, on June 4, 2026.

Newspaper Publication Details

The extract of the standalone audited financial results was published as an advertisement in newspapers pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The following table summarises the key publication details:

Regulatory Compliance

The publication was made in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. Copies of the newspaper advertisements were enclosed with the intimation letter submitted to BSE Limited. The submission was signed by Nishant Kankaria, Company Secretary and Compliance Officer of Samrat Pharmachem Limited, with a digital signature dated June 4, 2026.

The filing confirms that Samrat Pharmachem Limited has met its obligations under the applicable SEBI listing regulations with respect to the public dissemination of its audited standalone financial results for the financial year ended March 31, 2026.

Samrat Pharmachem Limited has formally declared to BSE Limited that it does not meet the criteria to be classified as a Large Corporate under SEBI regulations. The company submitted this declaration on April 7, 2026, as part of its regulatory compliance obligations.

Regulatory Declaration Details

The pharmaceutical chemicals manufacturer confirmed its status through an official communication to the Department of Corporate Services at BSE Limited. The declaration specifically references SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, which establishes the criteria for Large Corporate classification.

Corporate Governance Compliance

The declaration was properly executed with dual authorization from key company officials. Company Secretary & Compliance Officer Nishant Kankaria and Chief Financial Officer Rajesh Mehta both digitally signed the document, ensuring adherence to corporate governance protocols.

Samrat Pharmachem Limited operates as a manufacturer and exporter of pharmaceutical chemicals, with its registered office and factory located in GIDC Phase 4, Ankleshwar, Gujarat, and corporate office in Andheri West, Mumbai.

Regulatory Significance

This declaration ensures the company remains compliant with SEBI's disclosure requirements regarding Large Corporate status. The SEBI circular establishes specific criteria that entities must meet to be classified as Large Corporates, with corresponding regulatory obligations and disclosure requirements.